Bunge Global SA (BG)

Rating: HOLD

HOLD (5-tier) · balance-sheet repair · conviction: low

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +5% vs spot
• Monte Carlo median implies -8% vs spot
• DCF fair value implies -88% vs spot — but this is terminal-value sensitive (exit-multiple $14 vs Gordon $27, 102% apart), so it carries less weight
• Bear case (Structural — Crush / Protein Margin Reset) downside is -64% vs spot
• Net: reward/risk of 0.1× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $106.73 (26 June 2026) Bunge trades on roughly 13.9x forward earnings against a 17.2x peer median. The market is pricing mid-cycle crush and merchandising margins on the enlarged post-Viterra revenue base of $80.5bn, with a visible discount for $15.45bn of net debt and unproven integration. The engine broadly shares that caution rather than disputing it. Scenario weights put 40% on margin-reset or trough paths, the Monte Carlo puts the probability of fair value above spot at 48.0%, and the capex-bridge DCF anchors at only $14.54 per share (Gordon variant $28.29) because a circa 2.3% operating margin leaves thin free cash after roughly $2bn of capex (FY2025 actual $1.723bn, AV as of 2025-12-31) — so the equity case rests on the multiple, not on cash generation. The probability-weighted target of $115.20 sits 7.9% above spot, inside the HOLD band. The single most damaging risk is a structural crush-capacity reset: that scenario prices at $40.44, well below the 52-week low of $69.64.

The dashboard below is the whole argument on one page: spot ($111) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The bear mechanism is a structural reset in global crush economics, not a soft quarter. Soybean crush capacity added for renewable diesel in North America and processing expansion in Brazil keeps running even if biofuel policy support fades; meal and oil supply then outpaces demand and crush margins settle structurally lower. Bunge earns roughly two cents of operating profit per revenue dollar, so a modest margin reset removes a large share of earnings. Viterra adds merchandising volume, not margin, and the $15.45bn of net debt taken to fund the combination restricts buybacks precisely when earnings compress. On that path earnings fall to roughly $4.04 per share, the multiple compresses to 10x, and the scenario prices at $40.44 — below the 52-week low of $69.64.

Key Debate

Gross Margin explains 65% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.23 vs analyst floor +0.08 → delta +0.15 (n=23 mgmt / 14 Q&A; 6th pctile across the S&P book, z -1.5).

Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).

News (last 365d, 1000 articles): avg ticker sentiment +0.19 (bullish 27% / bearish 4%)

Scenario Analysis

The tree runs from a structural 'Structural — Crush / Protein Margin Reset' downside ($40) to a 'Spike — Supply Dislocation' bull case ($242); the probability-weighted blend (PWEV $116) is +5% versus spot.

Scenario rationale — what each probability buys (the driver path behind every target):

• Structural — Crush / Protein Margin Reset (22%, $40). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 40.44; probability: 0.22.
• Cyclical Margin Trough (18%, $69). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising. Drivers — implied_target: 72.0; probability: 0.18.
• Base — Mid-Cycle Crush / Protein Margins (32%, $116). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns. Drivers — implied_target: 116.88; probability: 0.32.
• Upcycle — Tight Margins (20%, $190). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 186.43; probability: 0.2.
• Spike — Supply Dislocation (8%, $242). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins. Drivers — implied_target: 233.18; probability: 0.08.

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

DCF excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $103 and 45% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (65% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 9.0%, 13x terminal FCF multiple → $14. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 17.235x) implies $132. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Across all anchors the spread is 290% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Consumer Staples — Ag

This name sits in the Consumer Staples — Ag as a ag_products. ag-processing crush margins / protein cycle + commodity & feed costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: ADM (ag_products) · BG (ag_products) · TSN (ag_products)

Mapping note: name-level 'Structural — Crush / Protein Margin Reset' (22%) + 'Cyclical Margin Trough' (18%) map to cluster Crush / Protein Margin Reset (40%); name-level 'Upcycle — Tight Margins' (20%) + 'Spike — Supply Dislocation' (8%) map to cluster Tight-Margin Upcycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Crush / Protein Margin Reset () — this name implies 40% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The staples_ag cycle is the shared macro driver. Driver — ag-processing crush margins / protein cycle + commodity & feed costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.0% · Σ PV(FCF) $5B + PV(terminal) $13B = EV $18B; + net cash → equity $3B ÷ diluted shares 0.20B = $14/share (exit-multiple terminal).

• Gordon (perpetuity-growth) terminal at 2.5% → $27/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 1% vs WACC 9% → below WACC — the incremental build is value-dilutive.

Peer set

Peer-median fwd P/E → $132; EV/Rev → $349.

Weighted fair-value math

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Agricultural Products & Protein multiple (AI re-rating) (base 15x)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 0.1% of revenue; cash conversion (OCF/NI) 98% — cash-backed.

Catalyst Calendar

• 2026-07-29 (~21d) — Quarterly earnings — est. EPS $2.00 (AV EARNINGS_CALENDAR)
• 2026-08-05 (~28d) — First full-quarter Viterra-consolidated results with synergy run-rate update (authored)
• 2026-11-04 (~119d) — FY2026 adjusted-EPS guidance at Q3 earnings (authored)
• 2027-01-31 (~207d) — US EPA biofuel blending / renewable-diesel mandate (RVO) decision (authored)

Forecast Track Record

• EPS surprise: beat 75.0% of the last 8 quarters; average surprise +22.1%.

Competitive Moat

Narrow moat. A narrow moat — global origination/logistics network and merchandising scale, but ~2c operating profit per revenue dollar and commodity price-taking — supports only a mid-teens terminal multiple, and only if crush margins normalise. FALSIFIABLE: if companywide operating margin holds below ~2.05% for two prints, the terminal multiple should compress toward 10-12x and the DCF terminal collapses given thin FCF after ~$2bn capex.

Moat sources:

• Global grain origination, storage and logistics network (asset footprint hard to replicate)
• Post-Viterra merchandising scale and information advantage in trading flows
• Integrated crush capacity across North America and Brazil
• No pricing-power moat — meal/oil prices are set by global supply-demand; crush margins are cyclical and mean-reverting

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

What the Market Is Pricing In

At the current price, the market pays 10.1× forward EPS, vs the house DCF terminal 13.0×, and a peer median 17.235×. The house DCF sits 88% below spot, so the market is pricing in more than the house case — roughly 1.4pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Peer Quality & Weighting

Quality-weighted forward P/E: 16.6× (simple median 17.235×). Direct peers count 100%, segment 50%, broad 25%.

Valuation-anchor screen: DCF (exit) (excluded (>3× or <0.3× spot)); DCF (Gordon) (excluded (>3× or <0.3× spot)). Anchor median 102.6. Extreme/excluded anchors carry no headline weight.

Historical-range cross-check: 52-week range $70–$135, centre $97 (-13% vs spot); spot sits at the 63th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Spike — Supply Dislocation): $242.

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (254.0); Capex intensity ±15% (39.0); Revenue CAGR ±3pp (26.0); Terminal × ±15% (20.0); WACC ±1pp (7.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Source Log

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 9%, terminal multiple 13×, FY+5 revenue $86B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Companywide operating margin (segment operating profit / revenue) < 0.0205 (2 consecutive prints → Crush / Protein Margin Reset). 2.05% is the midpoint of the base (2.3%) and cyclical-trough (1.8%) margin drivers. Two prints below it falsify the mid-cycle margin that carries the $116.88 base target and moves the name onto the trough or reset path.
• Full-year adjusted EPS guidance ($) < 6.75 (single event → Crush / Protein Margin Reset). 6.75 is the midpoint of the base-scenario EPS (~7.75, consistent with the ~13.9x forward multiple at spot) and the trough EPS (~5.77). A guidance cut below that line is management conceding the crush cycle has rolled over before Viterra synergies land.
• Revenue growth (YoY) < -0.005 (2 consecutive prints → Crush / Protein Margin Reset). -0.5% is the midpoint of the base (growth of 2%) and cyclical-trough (-3%) growth drivers on the combined revenue base. Sustained contraction on an enlarged asset footprint means volumes and pricing are rolling over together, not a one-quarter timing effect.
• Net debt ($B) > 17.0 (2 consecutive prints → Crush / Protein Margin Reset). Net debt stands at $15.45B after funding the Viterra combination. Two prints above $17B, beyond normal readily-marketable-inventory seasonality, means deleveraging has stalled while earnings carry the debt — the balance-sheet leg of the HOLD case fails and buybacks are off the table.
• Annual capital expenditure ($B) > 2.6 (single event → Crush / Protein Margin Reset). The grounded schedule tops out near $2.1B (FY25 actual $1.723B, part-year Viterra). A full-year print above $2.6B signals integration cost overrun or forced maintenance spend across the enlarged asset base, eroding the already-thin free cash flow that the capex-bridge DCF shows.

Fact / Inference / Speculation

• FACT: Spot $111; 52-week range $70–$135; engine rating HOLD; base-case target $115 (+4%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
• INFERENCE: Triangulated FV $115 (+4% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: HOLD

Balanced: triangulated fair value $73 (-34% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

• No suitability assessment has been performed for any individual.
• Market data may be delayed or inaccurate; figures are as of the analysis date.
• Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
• Forecasts are uncertain; past performance is not indicative of future returns.
• The author or publisher may hold positions in securities mentioned.
• Users should verify information against primary sources (company filings) before acting.
• Investing involves risk of loss; there is no guarantee any target price is achieved.
• Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.